[HTML][HTML] Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced …

S Zhou, Y Yang, Q Zhang, C Zhu, P Cai… - Annals of Translational …, 2023 - ncbi.nlm.nih.gov
Background Esophageal cancer is one of the most common malignant tumors in China.
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …

Efficacy and prognostic analysis of 315 stage I–IVa esophageal cancer patients treated with simultaneous integrated boost-intensity-modulated radiation therapy

P Cai, Y Yang, DJ Li - Cancer Management and Research, 2021 - Taylor & Francis
Purpose Use of simulated integrated boost-intensity-modulated radiation therapy (SIB-IMRT)
is rarely reported in the treatment of esophageal cancer. This study was performed to …

Clinical efficacy and prognostic factors of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma

W Bai, Y Song, Y Qiao, L FU, R Zhang… - Chinese Journal of …, 2018 - pesquisa.bvsalud.org
Objective To evaluate the clinical efficacy and analyze relevant prognostic factors of
simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT) for …

The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A …

Y Xu, Z Wang, G Liu, X Zheng, Y Wang… - Journal of cancer …, 2016 - journals.lww.com
Purpose: To evaluate the clinical efficacy and toxicity of simultaneous integrated boost
intensity-modulated radiotherapy (SIB-IMRT) in patients with esophageal squamous cell …

Definitive simultaneous integrated boost versus conventional-fractionated intensity modulated radiotherapy for patients with advanced esophageal squamous cell …

C Li, L Tan, X Liu, X Wang, Z Zhou, D Chen… - Frontiers in …, 2021 - frontiersin.org
Background The aim of this study was to compare the effects of simultaneous integrated
boost–intensity modulated radiotherapy (SIB-IMRT) and conventional fractionated-IMRT (CF …

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in …

W Lan, L Lihong, H Chun, L Shutang, W Qi… - Strahlentherapie und …, 2022 - Springer
Objective This study aimed to evaluate the efficacy and safety of simultaneous integrated
boost intensity-modulated radiotherapy (SIB-IMRT) versus standard-dose intensity …

Comparison of Simultaneous Integrated Boost and Late-course Boost Intensity-modulated Radiation Therapy in the Treatment of Esophageal Carcinoma

Y Xiao, G Du, J Hu, T Wu, X Meng, B Tan - 2021 - researchsquare.com
This paper aimed to analyze and compare the outcomes of esophageal carcinoma treated
with simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT) and …

[PDF][PDF] Efficacy and safety of simultaneous integrated boost intensity-modulation radiation therapy combined with systematic and standardized management for …

W Deng, X Zhang, J Su, C Song, J Xu, X Zhao… - Frontiers in …, 2022 - frontiersin.org
Objective To analyze and compare the efficacy and safety of simultaneous integrated boost
intensity-modulation radiation therapy (SIB-IMRT) combined with systematic and …

Late toxicities, failure patterns, local tumor control, and survival of esophageal squamous cell carcinoma patients after chemoradiotherapy with a simultaneous …

C Chen, J Chen, T Luo, S Wang, H Guo, C Zeng… - Frontiers in …, 2021 - frontiersin.org
Purpose We aimed to evaluate the long-term outcomes of concurrent chemoradiotherapy
(CCRT) with a simultaneous integrated boost (SIB) of radiotherapy for esophageal …

[HTML][HTML] Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma. Early results of a phase II study

WW Yu, ZF Zhu, KL Zhao, JF Mao, KL Wu… - Strahlentherapie und …, 2014 - osti.gov
The safety and efficacy of using simultaneous integrated boost intensity-modulated
radiotherapy (SIB-IMRT) for patients with esophageal squamous cell carcinoma were …